Medifast (NYSE:MED) Releases FY23 Earnings Guidance
Medifast (NYSE:MED – Get Free Report) issued an update on its FY23 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $8.65-$9.55 for the period, compared to the consensus estimate of $8.53. The company issued revenue guidance of $1.05-$1.07 billion, compared to the consensus revenue estimate of $1.09 billion. Medifast […]
More Stories
NewEdge Advisors LLC Sells 410 Shares of First Community Bankshares, Inc. (NASDAQ:FCBC)
NewEdge Advisors LLC decreased its position in First Community Bankshares, Inc. (NASDAQ:FCBC – Free Report) by 21.3% during the 4th...
Albertsons Companies, Inc. (NYSE:ACI) Stock Position Decreased by NewEdge Advisors LLC
NewEdge Advisors LLC lowered its holdings in Albertsons Companies, Inc. (NYSE:ACI – Free Report) by 20.3% during the fourth quarter,...
Marshall Wace LLP Has $463,000 Stock Holdings in ProAssurance Co. (NYSE:PRA)
Marshall Wace LLP increased its position in ProAssurance Co. (NYSE:PRA – Free Report) by 21.0% in the 4th quarter, according...
Marshall Wace LLP Purchases New Position in Woodward, Inc. (NASDAQ:WWD)
Marshall Wace LLP acquired a new position in shares of Woodward, Inc. (NASDAQ:WWD – Free Report) in the fourth quarter,...
Marshall Wace LLP Sells 27,500 Shares of Organon & Co. (NYSE:OGN)
Marshall Wace LLP lowered its holdings in shares of Organon & Co. (NYSE:OGN – Free Report) by 48.7% in the...
Marshall Wace LLP Purchases Shares of 14,414 Rayonier Inc. (NYSE:RYN)
Marshall Wace LLP acquired a new position in Rayonier Inc. (NYSE:RYN – Free Report) during the 4th quarter, according to...